Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.
about
The NV gene of snakehead rhabdovirus (SHRV) is not required for pathogenesis, and a heterologous glycoprotein can be incorporated into the SHRV envelopeCrystal structure of the matrix protein VP40 from Ebola virusViral membrane scissionAttenuated vesicular stomatitis viruses as vaccine vectorsIn Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion.Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction.A coevolution analysis for identifying protein-protein interactions by Fourier transformThe 5' terminal trailer region of vesicular stomatitis virus contains a position-dependent cis-acting signal for assembly of RNA into infectious particles.Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimerasProtection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challengeThe membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G proteinInfluenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 proteinVirus maturation by budding.A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.Heterologous exchanges of the glycoprotein and the matrix protein in a Novirhabdovirus.Requirements for budding of paramyxovirus simian virus 5 virus-like particles.Ebola virus VP40 drives the formation of virus-like filamentous particles along with GPRoles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5.The C-terminal end of parainfluenza virus 5 NP protein is important for virus-like particle production and M-NP protein interaction.Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenicThe baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteinsInfectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein.Organization of the vesicular stomatitis virus glycoprotein into membrane microdomains occurs independently of intracellular viral components.Nonsegmented negative-strand viruses as vaccine vectors.Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccineVesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesA recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infectionPreferential Budding of Vesicular Stomatitis Virus from the Basolateral Surface of Polarized Epithelial Cells Is Not Solely Directed by Matrix Protein or GlycoproteinBaculovirus as a vaccine vectorAttenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in miceThe glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread.Plasma membrane microdomains containing vesicular stomatitis virus M protein are separate from microdomains containing G protein and nucleocapsids
P2860
Q24563525-A01F9370-34CB-4463-922E-52363E29CBF5Q24599743-9BE71611-F734-47D9-A0BA-AE37BDC6AF22Q27000780-2E67F163-12A3-4B63-AC40-961DD5A5DA44Q27469358-4C53DDBF-86AF-44B6-A739-863E437D936CQ30389455-7B5D5659-4A74-47B8-A1DA-8187E8C0FB7DQ31016943-879F1B27-AAC9-4011-9B11-00761AEC2DB8Q33590251-E677F0E4-2D69-4250-A84C-87119BF1683FQ33639235-110C6498-0A94-4F0D-B616-9A431D7C217FQ33639849-1BF2A662-B719-4167-84A0-912FDA419565Q33645178-9C55352A-0880-4948-9700-301C62330A16Q33725635-7A292B5F-DA37-484C-8FF4-94B5427843DCQ33743852-18A95DB4-AC2D-4039-BA8B-A11048479861Q33783986-30E963E9-6FB8-491A-94EA-8FCBEBF6C2ABQ33798704-D3E4C13B-7580-47A0-A97A-7EA8954A21F9Q33820965-0C978CC5-32EA-4C55-A310-11A68A014C61Q33865069-F438498C-6FE0-4FEA-B405-540CEEAB1BB5Q33914921-FDF37064-4E57-420D-AA8E-CB58993D1FE5Q34068037-9560A111-1F04-431F-9BF7-5175FC34162CQ34172295-266BBC6F-F61E-4C58-B0F4-645660F991D7Q34317031-90FC72DF-6EFB-4AF4-8B3E-42DB7ED20794Q34332631-414384CE-93F7-4C54-91A3-2B05B346DAACQ34336746-D67DE2F1-AB23-493F-8065-97DC68D64E39Q34338585-39220CD5-61A2-4202-98B6-829B720364C6Q34345181-581909F7-71F6-4222-A763-AF8F3F9EDC0BQ34416415-4401B094-92F5-40B6-BB88-0BF2B5605462Q34461764-C484D31C-7653-4A4E-89A8-8EDEC9316B22Q34553841-3AA41A63-4730-4850-B649-FC4F8DFE878DQ34744464-68E2BA7A-767E-4275-95C6-AA99F716EE2BQ34781925-30AE53CE-4434-4D4A-9169-F5D64E1F6313Q35139219-BF5A3FE3-0471-49F9-9B54-54593023E8BEQ35184639-E957500D-E08A-4E59-8410-097A95B06648Q35531542-4FBCA078-705A-4D0E-8A6A-12D0F464EDEDQ35635393-F06562BA-AC63-4F30-8A76-49A9F1195A41Q35781967-CE8A5409-06E0-47F2-9431-3049110ED67EQ35853085-A2D3556A-90A8-4531-A197-803E7FB2A651Q36281798-BD5E8355-CC7F-43F1-A89A-E76F4F5AEC40Q36337148-6D961725-7FCD-468B-B179-F23CBFA99AA1Q36423935-FBAC0390-9F9D-4346-8806-1C5D367E75DDQ36483804-2CA89833-745C-408C-A460-CDD9AF82C60CQ36673397-8CB33819-B300-49A0-B16F-8979B89ED38F
P2860
Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Requirement for a non-specific ...... of vesicular stomatitis virus.
@en
type
label
Requirement for a non-specific ...... of vesicular stomatitis virus.
@en
prefLabel
Requirement for a non-specific ...... of vesicular stomatitis virus.
@en
P2093
P2860
P356
P1433
P1476
Requirement for a non-specific ...... of vesicular stomatitis virus.
@en
P2093
P2860
P304
P356
10.1093/EMBOJ/17.5.1289
P407
P577
1998-08-01T00:00:00Z